Cancer‐Associated Fibroblast‐Derived miR‐483‐5p Promotes Liver Cancer Cell Proliferation and Stemness via MOAP1 Downregulation
Journal of Cellular Physiology · 2026-11 · 241 (11)
DOI: 10.1002/jcp.70257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Physiology, online erschienen am 15.11.2026. Verfasst von Hong Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Inner Mongolia People's Hospital, People's Hospital of Inner Mongolia University, Hohhot, Inner Mongolia, P.R. China. Hauptthemen laut MEDLINE: MicroRNAs, Cell Proliferation, Liver Neoplasms, Cancer-Associated Fibroblasts. Die Arbeit nennt 56 Literaturangaben. Gefördert von: Natural Science Foundation of Inner Mongolia Autonomous Region, Joint project of Inner Mongolia Medical University, Health and family planning research project of Inner Mongolia autonomous region.
Abstract (Originalsprache)
Within the tumor microenvironment (TME), cancer‐associated fibroblasts (CAFs) play an important role in liver cancer progression through intercellular communication, including the release of small extracellular vesicles (sEVs). This study investigated the potential mechanisms underlying the effects of CAF‐associated miR‐483‐5p on liver cancer progression. sEV‐enriched preparations were isolated from CAFs transfected with a miR‐483‐5p mimic or an antisense oligonucleotide (ASO) and subsequently used to treat HepG2 cells. These preparations were designated as CAF‐sEV‐miR‐483‐5p‐mimic and CAF‐sEV‐miR‐483‐5p‐ASO, respectively. To evaluate cell proliferation and stemness, colony formation and spheroid formation assays were applied. Additionally, a subcutaneous xenograft model in nude mice was established to assess the in vivo effects of these CAF‐derived sEV‐enriched preparations. MiR‐483‐5p enhanced HepG2 cell proliferation, stemness, and migration, and higher miR‐483‐5p expression was associated with poorer patient prognosis. CAF‐derived sEV‐enriched preparations was associated with increased miR‐483‐5p levels in HepG2 cells, suggesting that these preparations may contribute to the regulation of miR‐483‐5p levels in recipient cells. The CAF‐sEV‐miR‐483‐5p mimic preparation promoted HepG2 cell proliferation and stemness while suppressing apoptosis. Luciferase reporter and reverse transcription quantitative polymerase chain reaction (RT‐qPCR) assays supported the direct interaction between miR‐483‐5p and the Modulator of apoptosis 1 (MOAP1) 3′ untranslated region (3′‐UTR) and showed that miR‐483‐5p negatively regulates MOAP1 expression. MOAP1 downregulation was associated with increased proliferation and stemness in HepG2 cells. Importantly, MOAP1 overexpression attenuated miR‐483‐5p‐induced increases in proliferation, migration, and stemness in HepG2 cells, as well as the upregulation of Wnt1, β‐catenin, Nanog, Sox2, and Oct4. Furthermore, miR‐483‐5p ASO reversed the effects of CAF‐derived sEV‐enriched preparations on miR‐483‐5p levels, MOAP1 expression, and HepG2 cell viability. In vivo, the CAF‐sEV‐miR‐483‐5p‐mimic preparation promoted xenograft tumor growth in nude mice. Collectively, CAF‐derived sEV‐enriched preparations may contribute to increased miR‐483‐5p levels and promote the growth and stemness of liver cancer cells, potentially through miR‐483‐5p‐mediated downregulation of MOAP1. These findings suggest that the miR‐483‐5p/MOAP1 regulatory axis may serve as a potential therapeutic target for liver cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Inner Mongolia People's Hospital, People's Hospital of Inner Mongolia University, Hohhot, Inner Mongolia, P.R. China.
- Institute of Cancer, Inner Mongolia People's Hospital, People's Hospital of Inner Mongolia University, Hohhot, Inner Mongolia, P.R. China.
- Department of Graduate School, Inner Mongolia Medical University, Hohhot, Inner Mongolia, P.R. China.
- Department of Graduate School, Baotou Medical College, Baotou, Inner Mongolia, P.R. China.
- Department of Nuclear Medicine, Shenzhen People's Hospital, Shenzhen, Guangdong, P.R. China.
- Department of Radiation Oncology, Peking University Cancer Hospital (Inner Mongolia Campus) & Affiliated Cancer Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, P.R. China.
ORCID-Profile: Xiangcheng Wang, Hao Yang
Förderung
- Natural Science Foundation of Inner Mongolia Autonomous Region
- Joint project of Inner Mongolia Medical University
- Health and family planning research project of Inner Mongolia autonomous region
- Education and Teaching Reform Project of Inner Mongolia Medical
- Inner Mongolia Medical University
- Science and Technology Program of the Joint Fund of Scientific Research for the Public Hospitals of Inner Mongolia Academy of Medical Sciences
- Natural Science Foundation of Inner Mongolia Autonomous Region of China
- Natural Science Foundation of Inner Mongolia
Zitieren
APA
Yang, H., Liu, H., Su, Z., Lu, C., Qiao, M., Zou, X., Luo, D., Li, H., Wang, X., & Yang, H. (2026). Cancer‐Associated Fibroblast‐Derived miR‐483‐5p Promotes Liver Cancer Cell Proliferation and Stemness via MOAP1 Downregulation. Journal of Cellular Physiology, 241(11). https://doi.org/10.1002/jcp.70257
Vancouver
Yang H, Liu H, Su Z, Lu C, Qiao M, Zou X, et al. Cancer‐Associated Fibroblast‐Derived miR‐483‐5p Promotes Liver Cancer Cell Proliferation and Stemness via MOAP1 Downregulation. Journal of Cellular Physiology. 2026;241(11). doi:10.1002/jcp.70257
BibTeX
@article{Yang2026,
author = {Yang, Hong and Liu, Huan and Su, Zenong and Lu, Chao and Qiao, Meng and Zou, Xiaohong and Luo, Danyang and Li, Haojing and Wang, Xiangcheng and Yang, Hao},
title = {Cancer‐Associated Fibroblast‐Derived miR‐483‐5p Promotes Liver Cancer Cell Proliferation and Stemness via MOAP1 Downregulation},
journal = {Journal of Cellular Physiology},
year = {2026},
volume = {241},
number = {11},
doi = {10.1002/jcp.70257}
}
EUVIMED